Junichi Sakamoto
Department of Epidemiological and Clinical Research Information Management
Kyoto University Graduate School of Medicine
Kyoto
Japan
Name/email consistency: high
- Phase II study of a 4-week capecitabine regimen in advanced or recurrent gastric cancer. Sakamoto, J., Chin, K., Kondo, K., Kojima, H., Terashima, M., Yamamura, Y., Tsujinaka, T., Hyodo, I., Koizumi, W. Anticancer. Drugs (2006)
- Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Sakamoto, J., Morita, S., Oba, K., Matsui, T., Kobayashi, M., Nakazato, H., Ohashi, Y. Cancer Immunol. Immunother. (2006)
- A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma. Sakamoto, J., Oriuchi, N., Mochiki, E., Asao, T., Scott, A.M., Hoffman, E.W., Jungbluth, A.A., Matsui, T., Lee, F.T., Papenfuss, A., Kuwano, H., Takahashi, T., Endo, K., Old, L.J. Cancer Sci. (2006)
- Efficacy of oral anticancer agents for colorectal cancer. Sakamoto, J., Oba, K., Matsui, T., Kobayashi, M. Dis. Colon Rectum (2006)
- An individual patient data meta-analysis of adjuvant therapy with carmofur in patients with curatively resected colon cancer. Sakamoto, J., Hamada, C., Rahman, M., Kodaira, S., Ito, K., Nakazato, H., Ohashi, Y., Yasutomi, M. Jpn. J. Clin. Oncol. (2005)
- Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials. Sakamoto, J., Ohashi, Y., Hamada, C., Buyse, M., Burzykowski, T., Piedbois, P. J. Clin. Oncol. (2004)
- A phase II Japanese study of a modified capecitabine regimen for advanced or metastatic colorectal cancer. Sakamoto, J., Kondo, Y., Takemiya, S., Sakamoto, N., Nishisho, I. Anticancer. Drugs (2004)
- Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives. Sakamoto, J., Morita, S., Kodera, Y., Rahman, M., Nakao, A. Cancer Chemother. Pharmacol. (2004)
- A phase II clinical trial to evaluate the effect of paclitaxel in patients with ascites caused by advanced or recurrent gastric carcinoma: a new concept of clinical benefit response for non-measurable type of gastric cancer. Sakamoto, J., Morita, S., Yumiba, T., Narahara, H., Kinoshita, K., Nakane, Y., Imamoto, H., Shiozaki, H. Jpn. J. Clin. Oncol. (2003)
- Efficacy of adjuvant immunochemotherapy with OK-432 for patients with curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials. Sakamoto, J., Teramukai, S., Nakazato, H., Sato, Y., Uchino, J., Taguchi, T., Ryoma, Y., Ohashi, Y. J. Immunother. (2002)









